Author ORCID Identifier
N/A
N/A
N/A
https://orcid.org/0000-0001-9562-4649
N/A
N/A
https://orcid.org/0000-0003-0959-3714
N/A
N/A
N/A
N/A
Document Type
Article
Publication Date
2019
College/Unit
School of Pharmacy
Department/Program/Center
Pharmaceutical Sciences
Abstract
MitoNEET (gene cisd1) is a mitochondrial outer membrane [2Fe-2S] protein and is a potential drug target in several metabolic diseases. Previous studies have demonstrated that mitoNEET functions as a redox-active and pH-sensing protein that regulates mitochondrial metabolism, although the structural basis of the potential drug binding site(s) remains elusive. Here we report the crystal structure of the soluble domain of human mitoNEET with a sulfonamide ligand, furosemide. Exploration of the high-resolution crystal structure is used to design mitoNEET binding molecules in a pilot study of molecular probes for use in future development of mitochondrial targeted therapies for a wide variety of metabolic diseases, including obesity, diabetes and neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease.
Digital Commons Citation
Geldenhuys, Werner J.; long, Timothy E.; Saralkar, Pushkar; Iwasaki, Toshio; Nuñez, Rasia A. A.; Nair, Rajesh R.; Konkle, Mary E.; Menze, Michael A.; Pinti, Mark V.; Hollander, John M.; Hazlehurst, Lori A.; and Robart, Aaron R., "Crystal Structure of the Mitochondrial Protein mitoNEET Bound to a Benze-sulfonide Ligand" (2019). Faculty & Staff Scholarship. 1965.
https://researchrepository.wvu.edu/faculty_publications/1965
Source Citation
Geldenhuys, W.J., Long, T.E., Saralkar, P. et al. Crystal structure of the mitochondrial protein mitoNEET bound to a benze-sulfonide ligand. Commun Chem 2, 77 (2019). https://doi.org/10.1038/s42004-019-0172-x
Comments
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/ licenses/by/4.0/.